Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast

Epidemiology

Volumn 9, Issue 5, 1998, Pages 570-573

  Bohlke, Kari ^a   Cramer, Daniel W ^a   Trichopoulos, Dimitrios ^a   Mantzoros, Christos S ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast neoplasms; Case control studies; Ductal carcinoma in situ; IGF I; IGFBP 3; Premenopausal

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CANCER RISK; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN LIKE ACTIVITY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN ISOLATION; RISK FACTOR;

EID: 0031840476     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199809000-00018     Document Type: Article

References (19)

1. LeRoith D, Clemmons D, Nissley P, Rechler MM. NIH Conference: insulin-like growth factors in health and disease. Ann Intern Med 1992;116:854-862.
2. Underwood LE, VanWyk JJ. Normal and aberrant growth. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 8th ed. Philadelphia: WB Saunders, 1992;1079-1139.
3. Helle SI, Lonning PE. Insulin-like growth factors in breast cancer. Acta Oncol 1996;35(suppl 5):19-22.
4. Pilichowska M, Kimua N, Fujiwara H, Nagura H. Immunohistochemical study of TGF-a, TGF-β1, EGFR and IGF-I expression in human breast carcinoma. Mod Pathol 1997;10:969-975.
5. Foekens JA, Portengen H, Janssen M, Klijn JGM. Insulin-like growth factor-1 receptors and insulin-like growth factor 1 like activity in human primary breast cancer. Cancer 1989;63:2139-2147.
6. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol. 1. The Analysis of Case-Control Studies. IARC Scientific Pub. No. 32. Lyon: International Agency for Research on Cancer, 1980.
7. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 1986;46:4613-4619.
8. Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 1988;48:4083-4092.
9. Peyrat JP, Bonneterre J. Type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat 1992;22:59-67.
10. Dunn SE, Hardman RA, Kari FW, Barrett JC. Insulin-like growth factor 1 (IGF-I) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 1997;57:2687-2693.
11. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 1993;90:11217-11221.
12. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells: cell surface binding and growth inhibition. J Biol Chem 1993;268:14964-14971.
13. Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 1997;3:1141-1144.
14. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A. Plasma insulin-like growth factor-1 (IGF-I) concentrations in human breast cancet. Eut J Cancer 1993;29A:492-497.
15. Bruning PF, Van Doom J, Bonfret JMG, Van Noord PAH, Kotse CM, Linders TC, Hatt AAM. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 1995;62:266-270.
16. Hankinson S, Pollak M, Michaud D, Willett W, Speizer F, the Nurses' Health Study Research Group. A prospective assessment of plasma insulin-like growth factor levels and breast cancer risk. Am J Epidemtol 1997;145: S72.
17. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami H-O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115-1118.
18. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Circulating insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998;279:563-566.
19. Hankey BP, Brinton LA, Kessler LG, Abtams J. Breast cancer. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, Edwards BJ, eds. SEER Cancer Statistics Review 1973-1990. NIH Pub. No. (NIH)93-2789. Washington DC: National Cancer Institute, 1993;IV.1-IV.4.